ATR Stock Analysis: Buy, Sell, or Hold?

ATR - AptarGroup, Inc.

PLASTICS PRODUCTS, NEC
$124.95
1.10 (0.89%) ▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 05, 2026 3d

Get Alerted When ATR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: ATR shows positive signals but monitor for confirmation. Market pricing in 0.3% annual growth which appears achievable. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$130.23
Based on 1.0% avg growth
INTRINSIC VALUE TODAY
$80.86
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ATR is currently trading at $124.95, which is considered slightly high relative to its 30-day fair value range of $122.20 to $125.36. The stock's valuation (Forward PE: 22.3) is in line with its historical norms (22.1). At these levels, the market is pricing in 0.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, ATR is in a downtrend. The price is currently testing key support at $122.58. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (9th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $159.14 (+27.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $122.20 - $125.36
Company Quality Score 56/100 (HOLD)
Options IV Signal 9th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 72.7%

All Signals

  • BULLISH: Options cheap (IV 9th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 27.4% below Wall St target ($159.14)
  • NEUTRAL: Market pricing in 0.3% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $122.20 - $125.36
Current vs Fair Value SLIGHTLY HIGH
Expected Move (7 Days) ±$5.14 (4.1%)

Support & Resistance Levels

Support Level $122.59
Resistance Level $126.99
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 22.32
Wall Street Target $159.14 (+27.4%)
Revenue Growth (YoY) 5.7%
Earnings Growth (YoY) 29.7%
Profit Margin 11.5%
Valuation Premium vs History +0.3% premium
PE vs Historical 22.3 vs 22.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.3% (market-implied from PE analysis)
1-Year Target $125.32 (+0%)
2-Year Target $125.70 (+1%)
3-Year Target $126.08 (+1%)
3-Yr Target (if PE normalizes) (PE: 22→22) PE COMPRESSION $124.85 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: -1.9%) $118.02 (+-6%)
Base: (SPY PE: 22.3, Growth: -1.9%) $117.93 (-6%)
Bear: (PE: 19.0, Growth: -1.9%) $100.24 (-20%)
📈 Valuation based on Current Earnings
Trailing PE: 19.86 | Current EPS (TTM): $6.23
Bull Case $122.28 (-2%)
Analyst growth -10.1%, PE expands to 21.8
Base Case $111.17 (-11%)
Market implied -10.1%, PE stable at 19.9
Bear Case $84.12 (-33%)
Severe decline -20.0%, PE contracts to 16.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 01, 2026 2:28 AM ET
Data refreshes hourly during market hours. Next update: 3:28 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Michael T. McCaul BUY 2025-09-22
Gael Touya SELL 2500 shares 2025-09-11
Michael T. McCaul BUY 2025-09-11

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALC
Alcon AG
STRONG BUY
27 analysts
$92 63 BUY
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$608 58 HOLD
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$191 58 HOLD
RMD
ResMed Inc
BUY
19 analysts
$292 57 HOLD
ALGN
Align Technology Inc
BUY
18 analysts
$184 62 BUY

Advanced ATR Option Strategies

Professional options setups generated by AI based on today's ATR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ATR

ATR Technical Chart ATR Price Prediction ATR Earnings Date ATR Investment Advisor ATR Fair Price Analyzer ATR Options Advisor ATR Options Chain ATR Options Analysis ATR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals